These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24631484)

  • 21. Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine.
    Cartmell J; Monn JA; Schoepp DD
    Psychopharmacology (Berl); 2000 Mar; 148(4):423-9. PubMed ID: 10928316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
    Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
    Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mGluR
    Sokolenko E; Hudson MR; Nithianantharajah J; Jones NC
    J Psychopharmacol; 2019 Dec; 33(12):1588-1599. PubMed ID: 31580222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine.
    Hudson MR; Rind G; O'Brien TJ; Jones NC
    Transl Psychiatry; 2016 Apr; 6(4):e784. PubMed ID: 27093066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impulsive behaviour in rats induced by intracortical DOI infusions is antagonized by co-administration of an mGlu2/3 receptor agonist.
    Wischhof L; Hollensteiner KJ; Koch M
    Behav Pharmacol; 2011 Dec; 22(8):805-13. PubMed ID: 22015807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat.
    Jones CA; Brown AM; Auer DP; Fone KC
    Psychopharmacology (Berl); 2011 Mar; 214(1):269-83. PubMed ID: 20607219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
    Hiyoshi T; Kambe D; Karasawa J; Chaki S
    Neuroscience; 2014 Nov; 280():262-74. PubMed ID: 25220900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics.
    Páleníček T; Fujáková M; Brunovský M; Balíková M; Horáček J; Gorman I; Tylš F; Tišlerová B; Soš P; Bubeníková-Valešová V; Höschl C; Krajča V
    Neuropsychobiology; 2011; 63(4):202-18. PubMed ID: 21422767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
    Greenslade RG; Mitchell SN
    Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.
    Orlando R; Borro M; Motolese M; Molinaro G; Scaccianoce S; Caruso A; di Nuzzo L; Caraci F; Matrisciano F; Pittaluga A; Mairesse J; Simmaco M; Nisticò R; Monn JA; Nicoletti F
    Neuropharmacology; 2014 Nov; 86():133-44. PubMed ID: 25063582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.
    Grivas V; Markou A; Pitsikas N
    Eur J Pharmacol; 2013 Sep; 715(1-3):105-10. PubMed ID: 23769742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression.
    Wischhof L; Koch M
    Psychopharmacology (Berl); 2012 Jan; 219(2):387-400. PubMed ID: 21863235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity.
    Woolley ML; Pemberton DJ; Bate S; Corti C; Jones DN
    Psychopharmacology (Berl); 2008 Feb; 196(3):431-40. PubMed ID: 18057917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats.
    D'Souza MS; Liechti ME; Ramirez-Niño AM; Kuczenski R; Markou A
    Neuropsychopharmacology; 2011 Sep; 36(10):2111-24. PubMed ID: 21654734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats.
    Swanson CJ; Schoepp DD
    J Pharmacol Exp Ther; 2002 Dec; 303(3):919-27. PubMed ID: 12438510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu₂/₃ receptor agonist, LY379268, is 5-HT₁A dependent.
    Wierońska JM; Sławińska A; Stachowicz K; Łasoń-Tyburkiewicz M; Gruca P; Papp M; Pilc A
    Behav Brain Res; 2013 Nov; 256():298-304. PubMed ID: 23948211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of mGlu2/3 agonist effects on ketamine-induced regional and event-related oxygen signals.
    Francois J; Gastambide F; Conway MW; Tricklebank M; Gilmour G
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4219-29. PubMed ID: 25943169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268.
    Johnson MP; Chamberlain M
    Neuropharmacology; 2002 Oct; 43(5):799-808. PubMed ID: 12384165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.